Caribou Biosciences (CRBU) Return on Sales: 2020-2025
Historic Return on Sales for Caribou Biosciences (CRBU) over the last 5 years, with Sep 2025 value amounting to -17.08%.
- Caribou Biosciences' Return on Sales fell 269.00% to -17.08% in Q3 2025 from the same period last year, while for Sep 2025 it was -17.08%, marking a year-over-year decrease of 269.00%. This contributed to the annual value of -14.92% for FY2024, which is 1196.00% down from last year.
- According to the latest figures from Q3 2025, Caribou Biosciences' Return on Sales is -17.08%, which was up 7.05% from -18.38% recorded in Q2 2025.
- In the past 5 years, Caribou Biosciences' Return on Sales registered a high of -3.08% during Q1 2021, and its lowest value of -18.38% during Q2 2025.
- For the 3-year period, Caribou Biosciences' Return on Sales averaged around -10.38%, with its median value being -8.50% (2023).
- Its Return on Sales has fluctuated over the past 5 years, first spiked by 432bps in 2023, then plummeted by 1,410bps in 2025.
- Caribou Biosciences' Return on Sales (Quarterly) stood at -6.97% in 2021, then slumped by 71bps to -7.68% in 2022, then spiked by 432bps to -3.37% in 2023, then tumbled by 1,331bps to -16.67% in 2024, then crashed by 269bps to -17.08% in 2025.
- Its Return on Sales stands at -17.08% for Q3 2025, versus -18.38% for Q2 2025 and -16.49% for Q1 2025.